Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

about

Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas.Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.

P2860

Q45035259-9DA8B120-0FAB-434E-8966-4B9C7F24FCFE Q55283747-B50E72D5-4EA6-4995-9D37-23ADE6FA459B

P2860

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

Item

http://www.wikidata.org/entity/Q36074644

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

@ast

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

@en

type

Item

label

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

@ast

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

@en

prefLabel

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

@ast

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

@en

P1476

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

@en

P2093

Antonella Bianchi

http://www.w3.org/2001/XMLSchema#string

Chiara Sarlo

http://www.w3.org/2001/XMLSchema#string

Francesca Chiodi

http://www.w3.org/2001/XMLSchema#string

Francesco M Quaranta-Leoni

http://www.w3.org/2001/XMLSchema#string

Giuseppe Avvisati

http://www.w3.org/2001/XMLSchema#string

Magdalena Cortes

http://www.w3.org/2001/XMLSchema#string

Ombretta Annibali

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients.

Rapidly increasing incidence of ocular non-hodgkin lymphoma.

Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients

Curative radiotherapy for primary orbital lymphoma.

Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.

Ocular adnexal non-Hodgkin's lymphoma: a review of epidemiology and risk factors

Extranodal marginal zone lymphoma of the ocular adnexa

Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma.

Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature.

Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

P304

895105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/895105

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Carlo Cosimo Quattrocchi

Stefano Bonini

P577

2015-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282832343

http://www.w3.org/2001/XMLSchema#string

P698

26425558

http://www.w3.org/2001/XMLSchema#string

P932

4575717

http://www.w3.org/2001/XMLSchema#string

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

about

P2860

P2860

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932